These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1199 related articles for article (PubMed ID: 17536875)

  • 21. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
    Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
    Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy.
    Nyunt MM; Adam I; Kayentao K; van Dijk J; Thuma P; Mauff K; Little F; Cassam Y; Guirou E; Traore B; Doumbo O; Sullivan D; Smith P; Barnes KI
    Clin Pharmacol Ther; 2010 Feb; 87(2):226-34. PubMed ID: 19776738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial.
    Madanitsa M; Kalilani L; Mwapasa V; van Eijk AM; Khairallah C; Ali D; Pace C; Smedley J; Thwai KL; Levitt B; Wang D; Kang'ombe A; Faragher B; Taylor SM; Meshnick S; Ter Kuile FO
    PLoS Med; 2016 Sep; 13(9):e1002124. PubMed ID: 27622558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suboptimal Intermittent Preventive Treatment in Pregnancy (IPTp) is Associated With an Increased Risk of Submicroscopic Plasmodium falciparum Infection in Pregnant Women: A Prospective Cohort Study in Benin.
    Hounkonnou CPA; Ndam NT; Fievet N; Accrombessi M; Yovo E; Mama A; Sossou D; Vianou B; Massougbodji A; Briand V; Cot M; Cottrell G
    Clin Infect Dis; 2021 Dec; 73(11):e3759-e3767. PubMed ID: 32901806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.
    Bertin G; Briand V; Bonaventure D; Carrieu A; Massougbodji A; Cot M; Deloron P
    Malar J; 2011 Jul; 10():196. PubMed ID: 21767415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.
    Clerk CA; Bruce J; Affipunguh PK; Mensah N; Hodgson A; Greenwood B; Chandramohan D
    J Infect Dis; 2008 Oct; 198(8):1202-11. PubMed ID: 18752443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes.
    Serra-Casas E; Menéndez C; Bardají A; Quintó L; Dobaño C; Sigauque B; Jiménez A; Mandomando I; Chauhan VS; Chitnis CE; Alonso PL; Mayor A
    J Infect Dis; 2010 Jan; 201(1):123-31. PubMed ID: 19954383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
    Walker PG; Floyd J; Ter Kuile F; Cairns M
    PLoS Med; 2017 Feb; 14(2):e1002243. PubMed ID: 28245259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania.
    Mikomangwa WP; Minzi O; Mutagonda R; Baraka V; Mlugu EM; Aklillu E; Kamuhabwa AAR
    Malar J; 2020 Apr; 19(1):160. PubMed ID: 32306955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Benin.
    Jafari-Guemouri S; Dhiab J; Massougbodji A; Deloron P; Tuikue NN
    Malar J; 2018 Oct; 17(1):356. PubMed ID: 30305101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.
    Sirima SB; Cotte AH; Konaté A; Moran AC; Asamoa K; Bougouma EC; Diarra A; Ouédraogo A; Parise ME; Newman RD
    Am J Trop Med Hyg; 2006 Aug; 75(2):205-11. PubMed ID: 16896120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact on pregnancy outcomes of intermittent preventive treatment with sulfadoxine-pyrimethamine in urban and peri-urban Papua New Guinea: a retrospective cohort study.
    Cellich P; Unger HW; Rogerson SJ; Mola GDL
    Malar J; 2024 Jul; 23(1):201. PubMed ID: 38970076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of sulfadoxine-pyrimethamine for the prevention of malaria-associated low birth weight.
    Wolfe EB; Parise ME; Haddix AC; Nahlen BL; Ayisi JG; Misore A; Steketee RW
    Am J Trop Med Hyg; 2001; 64(3-4):178-86. PubMed ID: 11442215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the usefulness of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a context with increased resistance of Plasmodium falciparum in Kingasani Hospital, Kinshasa in the Democratic Republic of Congo.
    Kayiba NK; Yobi DM; Tchakounang VRK; Mvumbi DM; Kabututu PZ; Devleesschauwer B; Mukomena ES; DeMol P; Hayette MP; Mvumbi GL; Rosas-Aguirre A; Lusamba PD; Speybroeck N
    Infect Genet Evol; 2021 Oct; 94():105009. PubMed ID: 34284138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal.
    Olliaro PL; Delenne H; Cisse M; Badiane M; Olliaro A; Vaillant M; Brasseur P
    Malar J; 2008 Nov; 7():234. PubMed ID: 18992140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of malaria in pregnancy.
    Desai M; Hill J; Fernandes S; Walker P; Pell C; Gutman J; Kayentao K; Gonzalez R; Webster J; Greenwood B; Cot M; Ter Kuile FO
    Lancet Infect Dis; 2018 Apr; 18(4):e119-e132. PubMed ID: 29395997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
    Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR
    Malar J; 2015 Feb; 14():69. PubMed ID: 25890159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine.
    Capan-Melser M; Mombo Ngoma G; Akerey-Diop D; Basra A; Würbel H; Groger M; Mackanga JR; Zoleko-Manego R; Schipulle U; Schwing J; Lötsch F; Rehman K; Matsiegui PB; Agnandji ST; Adegnika AA; Bélard S; González R; Kremsner PG; Menendez C; Ramharter M
    J Antimicrob Chemother; 2015; 70(6):1898-902. PubMed ID: 25722300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of monthly intermittent preventive treatment with dihydroartemisinin-piperaquine with and without azithromycin versus monthly sulfadoxine-pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled trial.
    Madanitsa M; Barsosio HC; Minja DTR; Mtove G; Kavishe RA; Dodd J; Saidi Q; Onyango ED; Otieno K; Wang D; Ashorn U; Hill J; Mukerebe C; Gesase S; Msemo OA; Mwapasa V; Phiri KS; Maleta K; Klein N; Magnussen P; Lusingu JPA; Kariuki S; Mosha JF; Alifrangis M; Hansson H; Schmiegelow C; Gutman JR; Chico RM; Ter Kuile FO
    Lancet; 2023 Mar; 401(10381):1020-1036. PubMed ID: 36913959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda.
    Braun V; Rempis E; Schnack A; Decker S; Rubaihayo J; Tumwesigye NM; Theuring S; Harms G; Busingye P; Mockenhaupt FP
    Malar J; 2015 Sep; 14():372. PubMed ID: 26410081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.